Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NetGenics was a bioinformatics software company that provided data integration and management solutions for the pharmaceutical and biotechnology industries. Its core offering, the SYNERGY platform, enabled researchers to federate disparate biological databases and streamline the drug discovery workflow. The company focused on improving the efficiency of genomic research and target identification through advanced informatics and middleware technology. By providing a unified interface for complex biological data, NetGenics helped researchers identify and validate novel drug targets more effectively. The company was acquired by the German informatics firm Lion Bioscience in 2002 to enhance its suite of drug discovery tools and expand its presence in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NetGenics.